Listening Sessions on Lowering Americans’ Drug Prices Through Competition

Sessions Information

As part of implementing President Trump’s Executive Order No. 14273, Lowering Drug Prices by Once Again Putting Americans First, the Justice Department’s Antitrust Division and the Federal Trade Commission, along with the Department of Commerce and the Department of Health and Human Services, will jointly host listening sessions to discuss ways to make prescription drugs more affordable for Americans by promoting competition. The three listening sessions will occur under the direction of Assistant Attorney General Gail Slater and FTC Chairman Andrew N. Ferguson.

The listening sessions will focus on improving the affordability of pharmaceuticals by increasing generic and biosimilar availability and promoting competition through drug formularies and benefits. The sessions, which will feature remarks by practitioners and scholars, will cover anticompetitive practices as well as eliminating regulatory barriers and rent seeking. The listening sessions will inform the FTC and DOJ’s joint report on combatting anticompetitive practices in pharmaceutical markets, as mandated by President Trump’s Executive Order.

The listening sessions will be streamed from each event page, linked below. After each session, videos and transcripts will be made available on each event page.

The agenda for the listening sessions will follow shortly.

Dates and Times